Page 2 - Senate Activity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mr. Huizenga thank you, mr. Chair. I stand here today to offer while i stand here today, as i offer my amendment, residents across the great lakes are facing imminent threats to their property, their infrastructure, and to the shore lines themselves due to historically high water levels. Great lakes communities, including many in my own district along the shores of lake michigan, are in critical need of shore line projects to protect against devastating erosion. For those of us who call the region home, the great lakes forever shapes our way of life. Its from we recreate, its where we do busin...

Mccarthy is trying to pass a shortterm funding bill many think he will have to reach out to democrats to do that. For democrats 202 7488000 if you want to talk about congress returning in the possible shutdown, for republicans 202 7488001, for independents 202 7488002 and for federal workers you can reach us at 202 7488003 and that social media you can do that at http twitter. Com cspanwj and facebook. Com cspan. What to expect when the house comes in you can follow that on our app, mccarthy says he wants to vote on a continuing resolution later this week. But this includes spending cuts thats...

Heather bresch, the 18 million a year of mylan of epipen tried to shift the blame on the lifesaving medication to insurers and drug benefit managers today. In an interview with cnbc, she also vowed to help reduce the cost of the emergency allergy drug for some people. As weve been reporting, the drugs retail price has risen more than 500 over the past decade, and that has causes a fierce reaction from customers on main street, lawmakers in washington and investors on wall street. Today Brian Sullivan asked mylans ceo the questions many want asking. Facing backlash from the government, the publ...

Heather bresch, the 18 million a year of mylan of epipen tried to shift the blame on the lifesaving medication to insurers and drug benefit managers today. In an interview with cnbc, she also vowed to help reduce the cost of the emergency allergy drug for some people. As weve been reporting, the drugs retail price has risen more than 500 over the past decade, and that has causes a fierce reaction from customers on main street, lawmakers in washington and investors on wall street. Today Brian Sullivan asked mylans ceo the questions many want asking. Facing backlash from the government, the publ...

A year of mylan of epipen tried to shift the blame on the lifesaving medication to insurers and drug benefit managers today. In an interview with cnbc, she also vowed to help reduce the cost of the emergency allergy drug for some people. As weve been reporting, the drugs retail price has risen more than 500 over the past decade, and that has causes a fierce reaction from customers on main street, lawmakers in washington and investors on wall street. Today Brian Sullivan asked mylans ceo the questions many want asking. Facing backlash from the government, the public and stock market, mylan ceo ...